Ordinary Index Rebalancing in the Solactive China Biotech Index | July 2020
In the ordinary rebalance the following composition and weights were implemented effective open 13.07.2020
| 3SBIO INC | 1.031829% |
| ANHUI ANKE BIOTECHNOLOGY G-A | 1.955298% |
| BEIGENE LTD-ADR | 6.371663% |
| BEIJING TIANTAN BIOLOGICAL-A | 1.395836% |
| BERRY GENOMICS CO LTD-A | 0.827181% |
| BETTA PHARMACEUTICALS CO L-A | 4.686199% |
| BGI GENOMICS CO LTD-A | 5.029519% |
| CANSINO BIOLOGICS INC | 1.010568% |
| CHINA BIOLOGIC PRODUCTS HOLD | 1.295357% |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 0.959930% |
| CHINA NATIONAL MEDICINES-A | 1.266172% |
| DA AN GENE CO LTD SUN YAT-A | 1.073871% |
| GENSCRIPT BIOTECH CORP | 1.302355% |
| HANSOH PHARMACEUTICAL GROUP CO | 3.125780% |
| HUALAN BIOLOGICAL ENGINEER-A | 3.669178% |
| HUTCHISON CHINA MEDITECH-ADR | 1.032003% |
| INNOVENT BIOLOGICS INC | 5.713950% |
| JIANGSU HENGRUI MEDICINE CO LTD CLASS A | 9.000003% |
| LIVZON PHARMACEUTICAL GROU-A | 1.280304% |
| NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO LTD | 0.691540% |
| PHARMABLOCK SCIENCES NANJI-A | 1.444557% |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 0.157756% |
| SHANGHAI RAAS BLOOD PRODUC-A | 2.356389% |
| SHENZHEN KANGTAI BIOLOGICA-A | 8.900753% |
| SHENZHEN SALUBRIS PHARM-A | 0.674291% |
| SINO BIOPHARMACEUTICAL LTD ORD | 7.455682% |
| WALVAX BIOTECHNOLOGY CO-A | 7.105483% |
| WUXI APPTEC CO LTD-A | 6.783567% |
| WUXI BIOLOGICS CAYMAN INC | 9.000002% |
| ZAI LAB LTD | 3.402982% |